Shree Ganesh Remedies cash flow

Latest FY26
Cash from operations
₹23.8cr−22.5% on FY25
Free cash flow
₹23.8cr−22.5% on FY25
Cash from financing
−₹11.7cr−₹1.1 cr in FY25
Cash from investing
−₹9.9cr−₹35.7 cr in FY25
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024
Adjustments to reconcile profit — non-cash items
10.59.6—
3.62.1—
−0.1−0.0—
−1.60.3—
Changes in working capital
−2.03.0—
−9.4−1.5—
3.5−2.2—
Cash from operating activities
24.031.338.2
4.810.1—
23.830.7—
Cash from investing activities
0.00.0—
0.10.0—
−9.9−35.7—
Cash from financing activities
−11.7−1.1—
2.2−6.1—
13.49.9—
Reference items
35.039.241.8
32.0%36.1%33.2%
23.830.7—
₹18.50₹23.88—
1.34×1.33×—
4.810.1—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SGRL₹658.00

Shree Ganesh Remedies Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSHUKRAPHARSUNLOCMcap ₹845 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation—9.610.5
+ Finance Costs—2.13.6
+ Interest Income—-0.0-0.1
+ Unrealised FX (Gain) / Loss—0.3-1.6
Changes in Working Capital
+ Inventories—3.0-2.0
+ Trade Receivables — Current—-1.5-9.4
+ Trade Payables — Current—-2.23.5
Cash from Operating Activities
Profit Before Tax (per I/S)38.231.324.0
+ Income Taxes Paid—10.14.8
Cash from Operating Activities—30.723.8
Cash from Investing Activities
+ Disp of Fixed Assets—0.00.0
+ Interest Received — Investing—0.00.1
Cash from Investing Activities—-35.7-9.9
Cash from Financing Activities
Cash from Financing Activities—-1.1-11.7
Net Changes in Cash—-6.12.2
Closing Cash—9.913.4
Reference Items
EBITDA41.839.235.0
EBITDA Margin %33.2136.1132.04
Free Cash Flow (CFO − Capex)—30.723.8
Free Cash Flow per Basic Share—23.8818.50
Cash Flow to Net Income—1.331.34
Cash Paid for Taxes—10.14.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.